References
- Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–38. doi:10.1002/lsm.20048.
- Saedi N, Ray Jalian H, Petelin A, Zachary C. Fractionation: past, present, future. Semin Cutan Med Surg. 2012;31:105–09. doi:10.1016/j.sder.2012.02.003.
- Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008;34:301–07.
- Alster TS, Khoury RR. Treatment of laser complications. Facial Plast Surg. 2009;25(5):316–23. doi:10.1055/s-0029-1243080.
- Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg. 1999;25(3):242–46. doi:10.1046/j.1524-4725.1999.08197.x.
- Setyadi HG, Jacobs AA, Markus RF. Infectious complications after non ablative fractional resurfacing treatment. Dermatol Surg. 2008;34:1595–98.
- Hirsch R. Iatrogenic laser complications. Clin Dermatol. 2011;29:691–95. doi:10.1016/j.clindermatol.2011.08.010.
- Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med. 2009;41:179–84. doi:10.1002/lsm.v41:3.
- Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg. 2010;36(3):299–306. doi:10.1111/j.1524-4725.2009.01434.x.
- Gilbert S, Mc Burney E. Use of valacyclovir for herpes simplex virus-1(HSV-1) prophylaxis after facial resurfacing: a randomized clinical trial of dosing regimens. Dermatol Surg. 2000;26:50–54. doi:10.1046/j.1524-4725.2000.99166.x.